Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 April 2024 | Story Anthony Mthembu | Photo Charl Devenish
Rea Parkies
Dr Reabetswe Parkies, Senior Officer in Marketing within the Faculty of Economic and Management Sciences at the University of the Free State (UFS), graduates with a PhD in Business Management at the April 2024 graduations.

The April 2024  graduations at the University of the Free State (UFS) mark a significant moment for graduates in the Faculty of Economic and Management Sciences (EMS),  including Dr Reabetswe Parkies, whose journey in attaining a PhD in Business Management has been one of dedication and perseverance.

Reflecting on the upcoming ceremony, Dr Parkies expressed mixed emotions, encapsulating the essence of her journey: ‘’As I prepare to walk across that stage, I'm filled with a mixture of emotions—excitement, pride, nostalgia, and perhaps a hint of apprehension about what lies ahead.’’ This moment represents the culmination of years of hard work and commitment to her academic pursuits.

Dr Parkies’s doctoral thesis, titled “Student self-employment in South Africa: A triple helix model, entrepreneurial competence and social support perspective,” delves into the complex dynamics of student entrepreneurship within the South African context. Her study aims to develop a comprehensive model for understanding self-employment, incorporating factors such as entrepreneurial competence, social support, and the role of the university, industry and government initiatives.

A culmination of years of hard work

The path to achieving her PhD was not without its challenges. Balancing her responsibilities as a Senior Officer in Marketing at the UFS with the demands of academic research required meticulous time management and personal sacrifice. ‘’As time went on, I found my rhythm and developed strategies to become more efficient and effective,’’ Dr Parkies explained. She credits her successful completion of the PhD to the unwavering support of her supervisors and her determination.

As she prepares to celebrate this milestone, Dr Parkies looks ahead to future contributions to her field. ’’By delving deeper into my area of expertise, I aim to uncover new insights and share these findings with the academic community through scholarly articles,’’ she remarked, emphasising her commitment to ongoing research and knowledge dissemination.

Dr Reabetswe Parkies's achievement serves as an inspiration to aspiring scholars and underscores the importance of perseverance and dedication in pursuing academic excellence. Her journey exemplifies the ethos of the University of the Free State in fostering academic growth and scholarly inquiry. 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept